Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies.

Zhang Z, Qu Y, Wang X, Ji Y, Yao J, Deng W, Sun G, Xu H, Chen X, Hong Q

DOI: 10.34133/research.1386
Published: 2026
Container: Research (Washington, D.C.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.34133/research.1386,
  title = {Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies.},
  author = {Zhang Z and Qu Y and Wang X and Ji Y and Yao J and Deng W and Sun G and Xu H and Chen X and Hong Q},
  year = {2026},
  journal = {Research (Washington, D.C.)},
  doi = {10.34133/research.1386},
  url = {https://doi.org/10.34133/research.1386}
}

RIS

TY  - JOUR
TI  - Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies.
AU  - Zhang Z
AU  - Qu Y
AU  - Wang X
AU  - Ji Y
AU  - Yao J
AU  - Deng W
AU  - Sun G
AU  - Xu H
AU  - Chen X
AU  - Hong Q
PY  - 2026
JO  - Research (Washington, D.C.)
DO  - 10.34133/research.1386
UR  - https://doi.org/10.34133/research.1386
ER  -

APA

Z, Z., Y, Q., X, W., Y, J., J, Y., W, D., G, S., H, X., X, C., & Q, H. (2026). Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies.. Research (Washington, D.C.). https://doi.org/10.34133/research.1386

Source records

pubmed · retrieved 2026-09-26T09:34:26.125Z
europe-pmc · retrieved 2026-09-26T09:34:26.149Z